In patients with T2DM who do not have atherosclerotic cardiovascular disease (ASCVD)/indicators of high-risk, HF, or CKD and who need to minimize hypoglycemia and/or promote weight loss, GLP-1 RAs are generally recommended as a second or third-line option as add-on to metformin therapy
Somatopause, which occurs in the 30s, is an event where growth hormone production dramatically decreases, and replacing growth hormone to address somatopause is a debated topic in the medical community 6m6s
Vial number: A sequential identifier so you can track which vial you are using
People taking medication to suppress the immune system after an organ transplant are also at higher risk
Company-Reported Usage Information The following reflects usage information published by the company and is not medical guidance
Oncotarget (2017) 8:5538493